Skip to content

Author

Bagas Ardiyantoro

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Analisis Docking Molekuler Senyawa Aktif Daun Mimba (Azadirachta indica) sebagai Inhibitor Lipase Beserta Modifikasi Senyawa Baru

The global prevalence of obesity reached approximately 15% in 2020 and is projected to rise to 18% by 2030, making the inhibition of pancreatic lipase activity to prevent the hydrolysis of triglycerides into free fatty acids and monoglycerides a crucial therapeutic strategy. This study aimed to analyze the root-mean-sq...

T. Listyani, Anna Fitriawati, Bagas Ardiyantoro et al. · 0 citations
Open access Sep 2026

Prediktor Keberhasilan Terapi Obat Anti Tuberkulosis (OAT) Pada Pasien TBC di Puskesmas Masaran 2

Tuberculosis (TB) remains a major public health problem in Indonesia, with Central Java among the five provinces with the highest case burden. The success of TB treatment is influenced by various predictive factors, both sociodemographic and clinical, which need to be identified to optimize therapeutic outcomes. This s...

Vanesha Aida Rahma Viona, Niken Luthfiyanti, Bagas Ardiyantoro · 0 citations
Open access Sep 2026

Cost-Effectiveness Analysis of the Use of the Antihypertensive Drugs Candesartan and Ramipril in Hospitalized Patients with Heart Failure and Hypertension

Heart failure is a complex syndrome that prevents the ventricles from pumping blood effectively. The high prevalence of heart failure in patients with hypertension and the need for long-term therapy increase healthcare costs, making clinical and economic evaluation necessary. This study aims to determine the cost-effec...

Dinda Herawati, Niken Luthfiyanti, Bagas Ardiyantoro · 0 citations
Open access Jul 2026

Molecular Docking Study of Active Compounds of Ketapang Leaves (Terminalia Catappa L.) Against Inhibitors Maltase Glucoamylase And Modification of New Compounds

Active compounds from ketapang leaves and the newly modified compound show promising potential as maltase-glucoamylase enzyme inhibitors via molecular docking.

T. Listyani, Nissa Syahraningtyas Putri, Bagas Ardiyantoro · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.